SA
Go ProLog In
SGRY
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
19 analysts·Moderate coverage
68
Score
14 Buy (74%)5 Hold (26%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1474%
Hold
526%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$17.00
+21.9%
Consensus
$19.00
+36.2%
Bull
$21.00
+50.5%
12-Month Target Range19 analysts
$17.00$19.00$21.00
Current $13.95Consensus
Current Price
$13.95
Upside to Consensus
$5.05

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+5.19%
EPS+48.94%
FY2028
Rev+7.04%
EPS+32.68%
FY2029
Rev+16.30%
EPS+44.31%

Earnings Surprises

Recent Analyst Actions

May 6, 2026Jefferies
Surgery Partners price target raised to $17 from $15 at Jefferies
Target:$17.00
+14.6%from $14.83
Apr 20, 2026Jefferies
Surgery Partners price target lowered to $15 from $16.25 at Jefferies
Target:$15.00
+5.1%from $14.27
Mar 11, 2026US Capital Advisors
UBS Reiterates Buy Rating on Surgery Partners (SGRY) Following Activist Letter to Shareholders
Target:$21.00
+55.6%from $13.50
Mar 4, 2026Jefferies
Surgery Partners (SGRY) PT Lowered to $16.25 at Jefferies
Target:$16.25
+13.9%from $14.27
Mar 4, 2026RBC Capital
Surgery Partners (SGRY) PT Lowered at RBC Capital as 2026 Guide Prompts Selloff
Target:$20.00
+40.7%from $14.21
Mar 3, 2026Jefferies
Benchmark Reiterates Buy Rating on Surgery Partners (SGRY) Following Q4 Results
Target:$30.00
+123.7%from $13.41
Dec 18, 2025Mizuho Securities
Surgery Partners price target lowered to $19 from $22 at Mizuho
Target:$19.00
+20.3%from $15.80
Nov 21, 2025Barclays
Surgery Partners price target lowered to $18 from $24 at Barclays
Target:$18.00
+17.6%from $15.30
Nov 17, 2025Mizuho Securities
Surgery Partners price target lowered to $22 from $28 at Mizuho
Target:$22.00
+44.7%from $15.20
Nov 13, 2024Jefferies
Surgery Partners (SGRY) PT Lowered to $40 at Jefferies
Target:$40.00
+34.5%from $29.74
Nov 13, 2024Barclays
Surgery Partners (SGRY) PT Lowered to $31 at Barclays
Target:$31.00
+4.2%from $29.74
Oct 14, 2024UBS
UBS Starts Surgery Partners (SGRY) at Buy
Target:$38.00
+24.8%from $30.46
Jun 28, 2024Macquarie
Macquarie Starts Surgery Partners (SGRY) at Outperform
Target:$31.00
+27.5%from $24.32
May 4, 2022Citigroup
Citigroup Maintains Buy on Surgery Partners, Raises Price Target to $64
Target:$64.00
+19.4%from $53.62

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance